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Abstract
Background: Assessing the quality of primary care is becoming a priority in national healthcare
agendas. Audit and feedback on healthcare quality performance indicators can help improve the
quality of care provided. In some instances, fewer numbers of more comprehensive indicators may
be preferable. This paper describes the use of the Summary Quality Index (SQUID) in tracking
quality of care among patients and primary care practices that use an electronic medical record
(EMR). All practices are part of the Practice Partner Research Network, representing over 100
ambulatory care practices throughout the United States.
Methods: The SQUID is comprised of 36 process and outcome measures, all of which are
obtained from the EMR. This paper describes algorithms for the SQUID calculations, various
statistical properties, and use of the SQUID within the context of a multi-practice quality
improvement (QI) project.
Results:  At any given time point, the patient-level SQUID reflects the proportion of
recommended care received, while the practice-level SQUID reflects the average proportion of
recommended care received by that practice's patients. Using quarterly reports, practice- and
patient-level SQUIDs are provided routinely to practices within the network. The SQUID is
responsive, exhibiting highly significant (p < 0.0001) increases during a major QI initiative, and its
internal consistency is excellent (Cronbach's alpha = 0.93). Feedback from physicians has been
extremely positive, providing a high degree of face validity.
Conclusion: The SQUID algorithm is feasible and straightforward, and provides a useful QI tool.
Its statistical properties and clear interpretation make it appealing to providers, health plans, and
researchers.
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Background
Assessment of the quality of primary care is becoming a
clear priority in national healthcare agendas. To evaluate
the care provided to patients with chronic illnesses and
clinical conditions that affect large segments of the popu-
lation, numerous quality indicators and performance
measures have been developed. For example, perform-
ance measurements by the US Centers for Medicare and
Medicaid Services (CMS) Physician Focused Quality Initi-
ative, including the Doctor's Office Quality Project, Doc-
tor's Office Quality Information Technology Project, and
Vista-Office Electronic Health Record, are being imple-
mented nationally to assess the care of Medicare benefici-
aries, support clinicians in providing appropriate
treatment, prevent avoidable health problems, and evalu-
ate the concept of pay-for-performance [1]. Other exam-
ples include performance measures endorsed by the US
National Committee for Quality Assurance, the National
Quality Forum, the American Medical Association/Physi-
cian Consortium for Performance Improvement, and the
Ambulatory Care Quality Alliance [1].
Implementation of research into clinical practice has been
facilitated through multiple QI strategies, including audit
and feedback [2,3]. Providing feedback to clinicians on
their performance related to specific indicators is one of
the components used to improve the quality of care pro-
vided. In situations such as this, where numerous quality
indicators are utilized, it has been argued that there may
be instances in which fewer numbers of more comprehen-
sive indicators are preferable [4]. For example, during
quality improvement (QI) projects involving multiple
process and/or outcome measures within multiple clinical
domains, efforts to improve quality in one area may yield
a decline in quality in another area. In such circumstances,
a summary measure may provide clinicians and research-
ers with a better sense of whether their efforts (or lack
thereof) result in net increases or decreases in quality.
Several earlier publications have discussed algorithms
used to summarize quality measures in different arenas of
the healthcare system. For example, CMS has developed a
system for summarizing quality indicators for hospitals
[5], and investigators with RAND Corporation have cre-
ated a mechanism for assessing overall quality of care pro-
vided to various communities around the US [6,7]. The
US Department of Veterans Affairs (VA) has developed
similar evidence-based measures, incorporating a "pre-
vention index" and a "chronic disease index" as a means
of encouraging better provider performance [8]. Likewise,
several papers have addressed statistical methodology
(e.g., latent variable models [9], factor analysis [4], and
Bayesian hierarchical regression models [10]) for physi-
cian, hospital, or health plan 'profiling,' in which an index
is created that compares the overall quality of care pro-
vided among various physicians. Global statistical tests
have also been proposed for comparisons of multiple cor-
related outcomes, typically used within the clinical trials
setting; however, their use in composite quality indices
has been minimal [11-14]. Although generally such
sophisticated statistical methods provide summaries
across multiple quality domains and account for correla-
tion among the individual measures of quality, with the
exception of the CMS, RAND, and VA methodologies, the
composite indices proposed in those papers do not have
a direct clinical interpretation. Additionally, these meth-
ods may be inadequate when the composite score
includes individual indicators that are not applicable to
selected groups of patients.
This paper outlines the construction, validation, and use
of the Summary Quality Index (SQUID), a composite
measure summarizing the quality of care provided by pri-
mary care providers. It was developed in the Practice Part-
ner Research Network (PPRNet), a practice-based research
network, for use in a QI demonstration project. PPRNet is
a network of ambulatory primary care clinicians through-
out the US who use a common electronic medical record
(Practice Partner, Seattle, WA). Data from outpatient
encounters (e.g., demographics, diagnoses, medications,
laboratory results, and vital signs) are remitted quarterly
to PPRNet staff at the Medical University of South Caro-
lina, where the data are prepared for analysis and summa-
rized in practice performance reports. Throughout this
process, only active adult patients over 18 years old are
included. Within PPRNet, a patient is considered active at
any point in time if he/she has had a progress note
recorded in the electronic medical record in the prior 12
months; a patient is considered to have an active medica-
tion if it was prescribed in the prior 12 months. As of the
third quarter 2005, 89 practices were represented.
Although the SQUID has been developed within the PPR-
Net setting, the algorithm used to create it is generalizable
to many other healthcare settings.
As a part of the QI demonstration project entitled Acceler-
ating the Translation of Research into Practice (A-TRIP),
an intervention which spanned 42 months (January 2003
through June 2006), this group of PPRNet clinicians has
been provided with quarterly reports on 36 unique qual-
ity indicators (see Table 1). Thirty-one of these indicators
are process measures, while five are outcome measures. As
is customary with performance measurement [15], the
indicators were chosen based on the ability of providers to
act on them, supporting evidence and national prevention
and disease management guidelines [16-28], and availa-
bility of data from the EMR. Chosen indicators are in the
following domains: prevention and management of
hypertension (HTN), coronary heart disease (CHD),
stroke, diabetes mellitus (DM), and respiratory/infectiousImplementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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disease, cancer screening, immunizations, substance
abuse and mental health, nutrition and obesity, and inap-
propriate prescribing in elderly patients. The A-TRIP QI
demonstration project was comprised of three specific
types of interventions: practice performance reports (audit
and feedback), optional semi-annual site visits to prac-
tices for academic detailing and participatory planning,
and optional annual network meetings to share 'best prac-
tice' approaches. The logic and supporting theory of the A-
TRIP intervention has been published elsewhere [29]. The
purpose of this paper is to summarize the development of
a statistically robust and clinically meaningful composite
summary measure that would help the research team and
individual practices evaluate the overall progress of a QI
demonstration project.
Methods
The algorithm for creating the composite quality measure
was developed during the A-TRIP project, which was
approved by the Institutional Review Board of the Medical
University of South Carolina. The algorithm for creating
the SQUID from the 36 quality measures includes 1)
determining which patients are eligible for which process
and outcome measures; 2) determining which patients
have met their desired clinical targets; and 3) calculating
SQUIDs for each patient and for each practice.
Determining which patients are eligible for which process 
and outcome measures
The first step in the SQUID algorithm involves counting
the number of process and outcome measures for which
the patient is eligible. For example, only patients with DM
are eligible for hemoglobin A1c (A1C) monitoring. An
indicator variable is thus created, with a one indicating
that a given patient is eligible (i.e., has DM) for the partic-
ular measure of interest (i.e., A1C monitoring), and a zero
indicating that the patient is not eligible (i.e., does not
have DM). These indicator variables are denoted by Ei,
where E1 is an indicator variable reflecting eligibility for
the first unique measure, E2 is an indicator variable reflect-
ing eligibility for the second unique measure, etc., and
where 'i' ranges from one to thirty-six, the total number of
unique process and outcome measures. The total number
of measures for which a patient is eligible is thus E =
. Note that patients with greater numbers of dis-
eases/medical conditions will be eligible for more process
and outcome measures, and thus the total (E) may be
used subsequently in analyses that need to adjust for the
level of patient complexity. Also, all adult patients over 18
years old are eligible for at least six process measures,
including blood pressure (BP), total cholesterol and high
density lipoprotein (HDL) cholesterol monitoring, teta-
nus/diphtheria vaccine, depression, and alcohol screen-
ing.
Determining which patients have met their desired targets
The next set of indicator variables reflects whether or not
the patient has met the targets for the eligible quality
measures. For process measures, the target has been met if
the process has been performed within some pre-specified
time frame (e.g., past six months, past year). For outcome
measures, the target has been met if the measure of inter-
est is under (in the case of BP, low density lipoprotein
[LDL], triglycerides, and A1C) or over (for HDL) the
guideline recommendation. These targets may vary
according to the patients' co-morbidities. For example, the
BP control target is less than 140/90 mmHg for patients
with HTN and less than 130/80 mmHg for patients with
DM. Patients with both HTN and DM need to meet the
more stringent target (i.e., less than 130/80 mmHg). The
relevant indicator variables (Mj's) are then summed so
that M, the total number of process/outcome targets that
a patient has met, is defined as M =  .
Calculating SQUIDs at the patient and practice level
Once E and M have been determined for each patient, the
patient-level SQUID is simply calculated by dividing M
(measures met) by E (eligible measures), thus reflecting
the proportion of relevant targets achieved for that
patient. Because the SQUID is a proportion, it ranges from
0.0% to 100.0%. Note that the SQUID incorporates both
individual process and outcome indicators, as has been
done for specific clinical domains in other studies [30,31].
Another feature of the SQUID is that it can be calculated
at the patient, provider, or practice-level. The practice-
level SQUID is calculated as the average of all the patient-
level SQUIDs among active patients in the practice. The
practice-level SQUID thus reflects the average proportion
of relevant targets achieved for patients in the practice. In
A-TRIP, provider-level SQUIDs were not reported; how-
ever, these could easily be calculated in other settings.
Use of the SQUID in QI
Once the patient-level and practice-level SQUIDs were
developed, they were incorporated into practice quality
performance reports provided to A-TRIP practices on a
quarterly basis. From January 2003 to April 1, 2005, par-
ticipating A-TRIP practices received quarterly performance
reports that only encompassed performance on the indi-
vidual quality measures. After April 1, 2005, practice
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reports included a statistical process control chart that
summarized the practices' performance on their practice-
level SQUID. These charts, similar to ones used for the
individual quality measures, mapped the practices'
SQUID scores on a monthly basis over the past 24
months. Practices were provided these reports as part of
the A-TRIP project through the end (i.e., June 2006) of the
QI project, and final analyses of the A-TRIP project
included an assessment of the change in practice-level
SQUID scores over the 3.5 year study time frame. The
analysis of the change in SQUID scores during A-TRIP was
also presented to providers during the 2005 and 2006 A-
TRIP network meetings, which were designed to help pro-
viders improve quality by listening to 'best practice'
approaches and by discussing their ideas with one
another. In fact, the 'best' practices were determined, in
part, by performance on their SQUID scores.
In addition to the practice-level reports, throughout the A-
TRIP QI effort practices have been provided with patient-
level reports, similar to a patient registry. These reports
consist of Excel spreadsheets with embedded filters and
macros that can help the practice identify their patients
not at goal on individual quality measures. Starting with
the 2nd quarter 2005 practice-level reports, the patient-
level SQUID was added to these reports. By having this
overall quality score calculated for individual patients,
practices were then able to identify, for example, their
patients with the lowest SQUID scores (i.e., those patients
with the lowest overall quality scores). They could also go
Table 1: A-TRIP quality indicators and eligibility criteria
Quality indicator Eligibility criteria Target
Process Measures
BP monitoring All adults Within past 6 months (DM or HTN); otherwise within past 2 
years
Total cholesterol measurement All adults Within past 5 years
HDL measurement All adults Within past year (DM); otherwise within past 5 years
LDL measurement DM, CHD, or other atherosclerotic disease Within past year
Triglyceride measurement DM Within past year
HgbA1C measurement DM Within past 6 months
Pap test Women without hysterectomy who are > = 18 years old but 
65 years old
Within past 3 years
FOBC, Sigmoidoscopy, or Colonoscopy Age > = 50 FOBC within past year, or sigmoidoscopy within past 5 years, 
or colonoscopy within past 10 years
Mammogram Women > = 40 years old Within past 2 years
Td vaccine Age > = 12 Within past 10 years
Flu vaccine Age > = 65 or [Age > = 18 and (DM, Asthma, COPD, CHD, 
HF, renal disease, or alcohol abuse)]
Within past year
Pneumococcal vaccine Age > = 65 or [Age > = 18 and (DM, Asthma, COPD, CHD, 
HF, renal disease, or alcohol abuse)], different frequencies
Ever
Hep A vaccines (n> = 2) Liver disease Ever
Chlamydia screening Women 16–25 years old Within past year
Depression screening Age > = 18 Within past 2 years
Alcohol screening Age > = 18 Within past 2 years
Alcohol counseling Alcohol abusers Within past year
Tobacco counseling Smokers Within past year
Diagnosing HTN Adults with 3 BPs > 140/90 mmHg in past year Diagnosis of HTN
Blood glucose test Obesity Within past year
Diet/nutritional counseling Obesity, HTN, hyperlipidemia, or DM Within past year
ACE or ARB (DM and HTN) or HF Active ACE or ARB Rx
Lipid lowering Rx CHD or other ASD Active lipid lowering Rx
Beta blocker HF Active beta blocker Rx
Anti-thrombotic agent AF or (> 40 years old and one or more of the following: HTN, 
hyperlipidemia, DM, other atherosclerotic disease)
Active aspirin or warfarin Rx (AF patients); otherwise active 
aspirin Rx
Anti-inflammatory agent Asthma Active anti-inflammatory agent Rx
Anti-depressant Depression Active anti-depressant Rx
Urinary microalbumin DM Within past year
Prescriptions with contraindications
Antibiotic agents URI, pharyngitis, or bronchitis in past month Antibiotic Rx within 3 days of visit for URI, pharyngitis, or 
bronchitis
Use of any drug that's always inappropriate Age > = 65 Active always inappropriate Rx
Use of any drug that's rarely appropriate Age > = 65 Active rarely appropriate Rx
Outcome Measures
BP control DM, HTN < 130/80 mmHg (DM) or < 140/90 mmHg (HTN)
HDL control DM > 45 mg/Dl
LDL control DM, CHD, or other atherosclerotic disease < 100 mg/Dl
Triglyceride control DM < 150 mg/Dl
HgbA1C control DM < 7%Implementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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a step further and identify the most complex patients
(using the SQUID denominator) with low SQUID scores,
to identify their more complex patients in need of
improved care.
Measuring SQUID reliability, responsiveness, validity, 
internal consistency, and distributional properties
Various statistical properties of the SQUID such as relia-
bility, responsiveness, validity, and distributional proper-
ties were also of interest. Reliability refers to the degree to
which two SQUID measures at different points close in
time are correlated with one another, while responsive-
ness refers to whether the index detects clinically mean-
ingful changes over time. To the extent that the patients'
electronic medical record data is accurate, the measure is,
by definition, essentially perfectly reliable. Responsive-
ness was investigated by examining the absolute increase
in patients' and practices' SQUID values during this 15-
month study period. Because the practices were participat-
ing in a QI project, it would be expected that patient-level
and practice-level SQUIDs would increase significantly
over time. Change over time was assessed for statistical
significance using paired t-tests, linear regression, and the
Wilcoxon sign test, as appropriate.
Validity refers to the degree to which the measure accu-
rately reflects that which is being measured. Although sev-
eral types of validity exist, we focused on face validity (i.e.,
a subjective assessment of whether the SQUID measures
that which it was intended to measure). This property was
assessed through an e-mail listserv for PPRNet members
and through informal interviews with providers who par-
ticipated in site visits or who attended the 2005 PPRNet A-
TRIP network meeting in Seattle, WA.
Other statistical properties were also examined. It has also
been recommended that performance measures based on
multiple measures need to have good internal consist-
ency, indicating that the individual items are measuring
similar constructs [32]. Internal consistency was meas-
ured using Cronbach's alpha coefficient among the prac-
tices' third quarter 2005 scores on the individual quality
indicators that comprise the SQUID. The intraclass corre-
lation coefficient to determine the proportion of patient-
level SQUID variation explained by practice membership
was also calculated, by using a mixed linear regression
model (SAS V9.1, Cary, NC), treating practice as a random
effect. The distribution of E (the total number of eligible
measures) was examined across the patient population to
provide a general sense of its distribution, including the
most frequent values observed and the associated variabil-
ity. Lastly, histograms were created for patient- and prac-
tice-level SQUIDs from third quarter 2005 for use in
determining their distributional properties, as this type of
information may provide further insight into the overall
nature of the variation in the quality of care provided. All
analyses were performed with SAS 9.1 (Cary, NC).
Results
The third quarter 2005 population studied included
330,966 active adult patients in 89 active PPRNet primary
care practices. Table 2 lists key descriptive statistics for
these practices and patients within the practices. Most
(78.7%) of the practices were family practices, with mul-
tiple providers. Of the diseases/conditions of interest, the
most frequently reported were hypertension (24.6%) and
hyperlipidemia (21.2%). A histogram reflecting the distri-
bution of the total number of eligible indicators (E) is
shown in Figure 1. Although E has a distribution that is
skewed to the right, the way our indicators are defined,
each adult has an E value that is 6 or greater. The median
of E is 9, and the mean is 10.6 (s.d. = 4.9).
The responsiveness of patient and practice-level SQUIDs
is highlighted in Table 3. Among patients who were active
during the entire 15-month time period, the mean SQUID
increased 3.6% (from 40.0% to 43.6%). Among all active
patients (during the quarter of interest), the mean SQUID
increased 3.2% (from 35.1% to 38.3%). Among practices
that were active during the entire 15-month time period,
the mean practice-level SQUID increased 3.8% (from
34.8% to 38.6%), with 88% of practices exhibiting a pos-
itive increase in their practice-level SQUID score. Addi-
tionally, analyses across the entire 3.5 year A-TRIP study
indicated an adjusted average annual improvement in the
SQUID of 2.43% (95% confidence interval 2.24% to
2.63%), an improvement that was consistent throughout
the entire study. These changes were all significantly dif-
ferent from zero (p < 0.0001). The reason why the mean
practice-level SQUIDs among patients active for the entire
study are lower than the mean patient-level SQUIDs is
due to patient turnover. The practice-level SQUIDs incor-
porate data from many patients who later became inactive
during the time period, as well as new patients who join
the practice. Since these two groups of patients did not
have continual contact with their practice during the 15-
month time period, their SQUID scores tended to be
lower than the patients who were active throughout the
study, thus reducing the values of the overall practice-level
SQUIDs.
When the SQUID algorithm and preliminary findings
were presented to clinicians participating in site visits or
attending the 2005 and 2006 PPRNet A-TRIP network
meetings, feedback was favorable. During site visits, pro-
viders and staff reviewed practice-level SQUIDs to further
assess their performance on A-TRIP measures. One prac-
tice used the trend of increasing SQUIDs to reinforce their
focus on improving process measures related to preven-
tive care (i.e., updating aspirin prescriptions in applicableImplementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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patients, and sending letters to patients overdue for mam-
mograms or colonoscopies). Another practice observed a
decreasing trend in practice-level SQUIDs related to
growth of their practice, and used their past performance
as motivation for providing quality care to an influx of
new patients. In general, providers appreciated the fact
that the SQUID was an index that had a direct interpreta-
tion of the overall quality of care provided in their prac-
tices.
When PPRNet e-mail listerv members were asked to pro-
vide feedback on the SQUID, several interesting responses
emerged, as they commented on how it was used in their
practices. Direct quotes from this informal feedback
request from physicians include:
"The SQUID ... provides an over-all indication of
whether or not a practice is on a 'trajectory of improve-
ment'. We find that there is 'psychic value' to knowing
that."
"It's nice to have along with the [other] two graphs
comparing us to the rest of the group. We just use it as
an overall assessment of how we're doing."
" [We] have been using it as some information for my
patients on how the practice does as a whole and for
negotiations with insurers."
"We have used this extensively. I presented our data to
the corporate fall conference. People were quite
impressed. The insurance companies we work with
also are excited about our improvements. We use the
summary to give an overall view to ourselves (provid-
ers), the associates (staff), and others in our network.
We follow this measure closely as a gauge of our
progress. It would be interesting to use it for specific
patients. We could have it to encourage compliance
and congratulate successes for certain patients. I envi-
sion presenting a graph of that particular person's
progress to him/her."
"Last year we had an influx of patients who work for
[company X] and were being seen by other docs. Our
summary indicator dipped and then came back up –
the people at [company X] were most happy. It is a
great lead-off slide for presentations...It is the future
for medicine."
Patients' third quarter 2005 SQUIDs correlated relatively
well (p < 0.0001) with their most recent systolic (r = -
0.17) and diastolic (r = -0.23) BP (DM and HTN patients
only), LDL (r = -0.26) (DM and CHD patients only), HDL
(r = 0.17) (DM patients only), triglycerides (r = -0.16)
(DM patients only), and A1C (r = -0.24) (DM patients
only) measurements. The directionality of these associa-
tions also provide evidence of construct validity for the
SQUID; that is, better overall quality was associated with
lower values of BP, A1C, LDL, and triglyceride measures as
Table 2: Characteristics of 89 active A-TRIP practices as of September 30, 2005
Characteristic Value
Specialty
Internal Medicine n (%) 15 (16.9)
Family Medicine n (%) 70 (78.7)
Multi-Specialty n (%) 3 (3.4)
Gynecology: n (%) 1 (1.1)
Number of providers: mean (s.d.) 5.2 (6.2)
Number of active patients: mean (s.d.) 3,936 (4,308)
Age of active adult patients: mean (s.d.) 47.6 (17.8)
Gender of active adult patients: % male 40.6
Prevalence of selected morbidities reported among active adult patients
Hypertension (%) 24.6
Hyperlipidemia (%) 21.2
Depression (%) 11.9
Diabetes mellitus (%) 8.7
Asthma (%) 5.3
Coronary heart disease (%) 3.3
COPD (%) 2.6
Heart failure (%) 1.4
Atrial fibrillation (%) 1.3
Alcohol abuse (%) 0.6
COPD: Chronic obstructive pulmonary diseaseImplementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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well as higher values of HDL. The Cronbach's alpha coef-
ficient among the practices' scores on the individual qual-
ity indicators was found to be 0.93, indicating excellent
internal consistency. Although a low internal consistency
would not necessarily be indicative of a poor composite
measure, the fact that the SQUID does have a high Cron-
bach's alpha coefficient suggests that it is comprised of
indicators measuring a common underlying quality con-
struct.
A histogram of the third quarter 2005 patient-level
SQUID values is shown in Figure 2. Note that approxi-
mately 4% of patients had SQUID values of zero, and the
relatively bimodal distribution, with peaks between 15%
and 20% and between 50% and 55%. A histogram of the
third quarter 2005 practice-level SQUID values is shown
in Figure 3. In contrast to the patient-level SQUIDs, the
practice-level SQUID distribution was uni-modal. The
average practice-level SQUID was 37.9%, with a standard
deviation of 10.7%. The practice-level SQUIDs ranged
from 12.3% to 68.3%, and the intra-class correlation coef-
ficient, reflecting the proportion of SQUID variation
explained by practice membership, was 23.8%.
Discussion
This paper describes the Summary Quality Index
(SQUID), a composite measure of healthcare quality in
the primary care setting. The SQUID has several advan-
Histogram of third quarter 2005 patient-level total number of eligible indicators (n = 350,307 patients) Figure 1
Histogram of third quarter 2005 patient-level total number of eligible indicators (n = 350,307 patients).
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Table 3: Quarterly means, standard deviations (s.d), correlations among patient-level SQUIDs
Quarter Mean1 (s.d.) patient-level SQUID 
(n = 212,054)
Mean2 (s.d.) patient-level SQUID [n] Mean (s.d.) practice-level SQUID 
(n = 85)
Third quarter 2004 40.0% (20.1%) 35.1% (20.7%) [324,595] 34.8% (10.9%)
Fourth quarter 2004 41.3% (19.9%) 34.8% (20.8%) [355,381] 35.1% (10.6%)
First quarter 2005 42.5% (19.8%) 35.5% (21.0%) [360,682] 36.1% (10.5%)
Second quarter 2005 43.3% (19.7%) 36.4% (21.0%) [362,712] 37.0% (10.5%)
Third quarter 2005 43.6% (19.8%) 38.3% (21.0%) [330,966] 38.6% (10.6%)
1 Mean SQUID among 212,054 patients active throughout entire study period
2 Mean SQUID among patients active during the quarter of interestImplementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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tages compared with other composite quality measures.
The algorithm is straightforward, and the resulting index
satisfies the qualities of good performance measures and
good outcome measures. Within the setting of A-TRIP, a
QI demonstration project, it has been shown to be a reli-
able, responsive, and valid measure of healthcare quality.
Feedback from clinicians suggests that this type of meas-
ure is quite appropriate and acceptable for primary care
settings. They appreciate its use for tracking a summary
measure of quality over time, and are excited about its
potential for appealing internally to their clinical and cler-
ical staff, as well as externally to insurers, corporate offi-
cials, and even their patients.
Having a patient-level composite measure is advanta-
geous for several reasons, most notably it allows for com-
parisons across groups of patients with specific conditions
(e.g., diabetes), demographics (e.g., the elderly), or types
of care (e.g,. preventive or chronic) [33]. In fact, a subset
of the A-TRIP quality indicators relevant to diabetes care
has already been used in the development of the Diabetes-
SQUID [30], which is ideal for studying ways to improve
care for diabetes patients in the primary care setting. Dur-
ing the A-TRIP project, making the patient-level SQUIDs
available to the clinicians responsible for the patients' care
has allowed those clinicians to identify their most clini-
cally complicated patients (i.e., based on the SQUID
denominator values) along with their patients with the
greatest need for care improvement (i.e., those with low
SQUID scores). Using a composite measure may also be
quite useful within QI projects involving multiple process
and/or outcome measures within multiple clinical
domains. Because efforts to improve quality in one area
may yield declines in other areas, a summary measure
may provide interested parties with a better sense of the
resulting net increases or decreases in performance.
Histogram of third quarter 2005 patient-level SQUIDs (n = 350,307 patients) Figure 2
Histogram of third quarter 2005 patient-level SQUIDs (n = 350,307 patients).
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Because the SQUID can be calculated at the patient level,
or aggregated to a higher level, such as that of the pro-
vider, practice, or health plan, it is useful from a variety of
perspectives. As mentioned earlier, practices may use the
patient-level SQUID to identify patients in most need of
certain types of care. However, they may also use their
practice-level SQUID as a marker of QI over time, or to
compare their progress against that of other practices in
their network. Health plans might use provider-level
SQUIDs to rank providers or track progress over time, and
researchers or QI organizations might use practice-level
SQUIDs to rank practices or track them over time.
Because the denominator (referred to as 'E' in the algo-
rithm) used in calculating the SQUID reflects the total
number of relevant indicators for a given patient, a rather
intuitive "complexity" adjustor is created in the process of
calculating each patient's SQUID. Although this value (E)
does not reflect the severity or duration of any individual
patient conditions, it does reflect an overall level of com-
plexity for that patient, because it includes a number of
unique chronic conditions that are commonly treated in
the primary care setting. This denominator can serve as a
covariate in patient-level regression models for the pur-
poses of complexity adjustment (analogous to risk adjust-
ment), or it can be averaged across patients to serve as a
complexity adjustor in provider or practice-level analyses.
This approach to quantifying overall quality of care is
emerging as a useful tool in practice, in QI, and in
research. Other algorithms mentioned in the literature for
composite quality measures have typically been aimed at
some aggregated level (rather than at the patient level),
such as those used in physician or health plan profiling
[4,5,9,10]. With the exception of the method described by
CMS for quantifying multiple quality measures for hospi-
tals [5], these algorithms involve the creation of some
composite index that typically has no direct clinical inter-
pretation. One set of methods that has been mentioned in
the medical literature for combining multiple patient-
level outcomes is the use of global statistical tests [11-14].
These tests can be an excellent way to account for corre-
lated outcomes among patients in clinical trials; however,
their effectiveness is limited when one or more of the out-
comes is not relevant for significant numbers of patients
(e.g., gender-specific measures such as whether a Pap test
has been done in the past 3 years). The SQUID algorithm
is similar to ones developed by CMS, RAND Corporation,
Histogram of third quarter 2005 practice-level SQUIDs (n = 89 practices) Figure 3
Histogram of third quarter 2005 practice-level SQUIDs (n = 89 practices).
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and the VA [5,7,8]. The CMS methodology, however, has
only been applied to the hospital setting, rather than at a
patient or physician level, and likewise the VA aggregate
indices are used as performance measures across groups of
patients. The RAND methodology is broader in nature but
relies on patient surveys and medical record abstracts.
There is much debate about the manner in which quality
of healthcare should be measured [34]. For example, there
are aspects of quality such as patient satisfaction, access to
care, certain health outcomes, and efficiency that are not
easily measured using electronic medical record or admin-
istrative data. Additionally, there is no consensus on
whether quality should be measured as a single construct
or as multiple domains [35]. Thus balancing what is prac-
tical and economical with what is desirable from various
perspectives (e.g., patients, providers, insurers, and
researchers) will likely continue to be a source of contro-
versy.
The SQUID satisfies the criteria for a good outcome meas-
ure that can be used in clinical research studies, including
being appropriate, reliable, responsive, precise, interpret-
able, acceptable, and feasible [36]. The SQUID also satis-
fies criteria for a desirable performance measure, as
defined in a consensus document of the American Medi-
cal Association, the Joint Commission on Accreditation of
Healthcare Organizations, and the National Committee
for Quality Assurance [37]. These criteria included being
of high priority for maximizing the health of persons or
populations, financially important, able to demonstrate
variation in care and/or the potential for improvement,
based on established clinical recommendations, poten-
tially actionable by users, and meaningful and interpreta-
ble to users. Another strength of this approach is that the
SQUID can be easily adapted to reflect revisions in evi-
dence for individual quality indicators.
The actual practice-level SQUID descriptive statistics
(mean: 37.9%; standard deviation: 10.7%; range: 12.3%
to 68.3%; intraclass correlation coefficient: 23.7%) may
seem as a cause for concern, especially when compared to
the RAND study's finding that adults in 12 metropolitan
areas in the US received 54.9 percent of recommended
care, ranging from 51% (Little Rock) to 59% (Seattle) [7].
However, the SQUID calculations for the PPRNet prac-
tices do rely on documentation of process of care within
certain specific areas of the electronic medical record com-
pared to patient telephone surveys and chart review by the
RAND investigators. Thus we may have underestimated
the true quality provided in these practices, due to some
physicians opting to record data in the records in a man-
ner (i.e., within the text of a progress note) that is not
obtainable via the current PPRNet data extraction process.
The intraclass correlation coefficient for the patient-level
SQUID (i.e., 23.8%) may seem relatively high in compar-
ison with ICCs for outcomes of other studies [38,39].
However, because these practices were all involved to with
a QI project during this time period, and since practices
were allowed to determine the extent to which they partic-
ipated in A-TRIP, we expected high variability in patient
healthcare quality and that practice membership would
explain much of this variation.
There are several limitations of this summary quality
measure. Currently, each of the individual processes and
outcomes comprising the SQUID is equally weighted, and
it could be argued that certain process or outcome indica-
tors should be weighted more heavily. Certain indicators
may be viewed as being more clinically important than
others, and other indicators may be easier to achieve than
others. It is also possible that certain individual processes
or outcomes may interact with one another, having syner-
gistic or even antagonistic effects on overall quality; how-
ever, examining the influence of such interactions was
beyond the scope of this study. Although it is possible that
indicator-specific weights could be incorporated into the
SQUID's summation formulas, deriving them would typ-
ically require building some type of group consensus or
using statistical methodology such as factor analysis or
item response theory methods [40]. One of the difficulties
of these empirical approaches in the context of our patient
population is the fact that many patients are not eligible
for multiple measures; thus trying to determine how indi-
cators cluster together or whether certain indicators are
more difficult than others would require much more in-
depth analyses that took into consideration eligibility dif-
ferences among patients. Even if such analyses were con-
ducted, resulting in a revised weighting scheme for each
indicator, we would argue that such a process would result
in a loss in the ease of interpretability of the SQUID, a fac-
tor we feel is key in communicating with an extremely var-
ied audience that includes providers with varied levels of
training and expertise (doctors, physician assistants,
nurses), office staff, and even patients. Item weighting (or
possibly item reduction) may, however, help address
another potential limitation of the SQUID, that some of
the individual indicators are correlated with one another.
For example, practices that do well in measuring patients'
total cholesterol routinely also tend to do well in measur-
ing their patients' HDL and LDL cholesterol levels. Future
research into possible weighting and/or item reduction
schemes for the individual indicators could help sort out
these issues. Additionally, as a general performance meas-
ure, the SQUID algorithm does not account for patient
allergies or other contraindications to immunizations or
medications; thus it would be virtually impossible for a
practice to achieve a practice-level SQUID score of 100%.
This fact is communicated to practices during site visitsImplementation Science 2007, 2:11 http://www.implementationscience.com/content/2/1/11
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and network meetings, and practices are given a sense of
what is practically achievable via internally derived
SQUID benchmarks. One other potential limitation of
the SQUID is the multi-modal nature of its distribution at
the patient-level and the fact that it is bounded by 0% and
100%. Thus caution should be used when analyzing
SQUID data from small numbers of patients. Lastly,
although the SQUID may be useful in detecting general
trends over time in quality, specific problematic areas
within a given practice are likely more easily identified via
individual- or condition-specific indicators.
Conclusion
The SQUID has been a helpful tool in quantifying overall
quality within the A-TRIP demonstration project. Provid-
ers have used the practice-level SQUIDs to assess overall
performance on quality indicators in 8 clinical domains,
and they have used the patient-level SQUIDs to identify
the patients in most need of attention. A-TRIP research
investigators have used it to identify practices making the
largest gains in overall QI. The ability to identify these
'best practices' allows us to encourage dialogue between
practices during annual A-TRIP network meetings, in
which physicians, nurses, and other office staff share ideas
to improve the quality of the care they provide. The
SQUID values have also served as the primary outcomes
in the final analyses of the A-TRIP project. Thus, it has
benefit to patients, practitioners, insurers, and researchers.
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